Amplitude Surgical Launches ACLip for ACL Reconstruction
Amplitude Surgical introduced the ACLip® device for anterior cruciate ligament reconstruction....
Dec 04, 2017,
Amplitude Surgical Launches ACLip for ACL Reconstruction
Globus Medical SECURE-C Disc vs. ACDF: 7-Year Follow-up
Results of seven-year clinical trial follow-up indicate superiority of Globus Medical’s SECURE-C® cervical disc vs. ACDF in the treatment of cervical disc disease....
Dec 01, 2017, Julie Vetalice
SeaSpine Gains FDA Clearance for OsteoBallast DBM in Resorbable Mesh
SeaSpine received FDA 510(k) clearance to market OsteoBallast™ Demineralized Bone Matrix in Resorbable Mesh....
Nov 30, 2017, Julie Vetalice
First US Procedures for Emerging Implant Technologies Spinal Cages
Emerging Implant Technologies announced completion of first U.S. procedures with its 3D-printed titanium spinal cages. ...
Nov 30, 2017, Julie Vetalice
K2M: 300 RHINE Cervical Disc Cases Completed
K2M announced completion of 300 surgical cases using the RHINE™ Cervical Disc....
Nov 30, 2017, Julie Vetalice
curasan Enters Distribution Agreement with Implantcast
curasan entered into an exclusive agreement with Implantcast for distribution of CERASORB bone regeneration products in Austria, Germany and Switzerland....
Nov 30, 2017, Julie Vetalice
Rotation Medical Bioinductive Implant Study Update
Study results indicate that Rotation Medical’s Bioinductive Implant may consistently heal rotator cuff tears, increase tendon thickness and prevent tear progression....
Nov 30, 2017, Julie Vetalice
Medtronic Posts FY2Q18 Revenue
ORTHOWORLD estimates Medtronic’s FY2Q18 revenue at US $739.0MM, -0.4% vs. FY2Q17 (quarter ended 10/27/17). The company posted YTD revenue of $2,226.0MM, +1.2%...
Nov 28, 2017, Julie Vetalice
Xtant Medical Reports 3Q17 Revenue
Xtant Medical posted 3Q17 revenue of US $19.8MM, -14.3% vs. 3Q16, with YTD revenue of $63.3MM, -3.4% vs. the prior year....
Nov 28, 2017, Julie Vetalice
Regentis Biomaterials Launches Phase III Pivotal Trial of GelrinC
Regentis Biomaterials commenced first surgeries in its Phase III pivotal clinical trial of GelrinC in the treatment of focal knee cartilage defects....
Nov 28, 2017, Julie Vetalice
Loading new posts...
No more posts
